Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I. (Q39934395)
Jump to navigation
Jump to search
scientific article published on 28 October 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I. |
scientific article published on 28 October 2009 |
Statements
1 reference
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I. (English)
1 reference
Louis P Garrison
1 reference
Joel W Hay
1 reference
Jim Smeeding
1 reference
Norman V Carroll
1 reference
Michael Drummond
1 reference
Edward C Mansley
1 reference
C Daniel Mullins
1 reference
Jack M Mycka
1 reference
Brian Seal
1 reference
Lizheng Shi
1 reference
28 October 2009
1 reference
1 reference
Identifiers
1 reference